Manhattan Associates (MANH) Cash & Equivalents (2010 - 2026)

Manhattan Associates (MANH) has 17 years of Cash & Equivalents data on file, last reported at $226.1 million in Q1 2026.

• Quarterly Cash & Equivalents rose 9.84% year-over-year to $226.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $226.1 million (up 9.84% YoY) and the FY2025 annual result came in at $328.7 million, up 23.48% from the prior year.
• Cash & Equivalents retreated to $226.1 million in Q1 2026 per MANH's latest filing, from $328.7 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $328.7 million in Q4 2025 and bottomed at $13.9 million in Q3 2022.
• The 5-year median for Cash & Equivalents is $112.6 million (2024), against an average of $147.1 million.
• The widest annual swing landed in 2023, when Cash & Equivalents surged 1211.6%; it then plunged 66.85% in 2025.
• Tracing MANH's Cash & Equivalents over 5 years: stood at $225.5 million in 2022, then grew by 20.08% to $270.7 million in 2023, then fell by 1.67% to $266.2 million in 2024, then climbed by 23.48% to $328.7 million in 2025, then tumbled by 31.21% to $226.1 million in 2026.
• Per Business Quant, the three latest MANH Cash & Equivalents figures stand at $226.1 million (Q1 2026), $328.7 million (Q4 2025), and $90.8 million (Q3 2025).

Peer Comparison